Randomized Controlled Trial of mirtazapine vs lithium as augmentation after SSRI/SNRI failure.
Not Applicable
- Conditions
- depression
- Registration Number
- JPRN-UMIN000008451
- Lead Sponsor
- Kansai Medical University Department of Neuropsychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects with clinically significant unstable medical illness, pregnancy, a principal psychiatric diagnosis other than major depression, a history of substance abuse or dependence active within the previous 6 months, and electroconvulsive therapy within the previous 6 months were excluded. Subjects with axis I disorder other than major depressive disorder and personality disorder was also excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HAM-D change after 3 months of treatment. Remission rate.
- Secondary Outcome Measures
Name Time Method Adverse effect